CLGN CollPlant Biotechnologies Ltd. - Ordinary Shares
NASDAQ · Biotechnology · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Mar 26, 2026
$3.46
· of 52w range
· above low
· to high
$2.6452w low
$26.8052w high
Market Cap
$44M
P/E
-3.7
EPS
$-0.94
Revenue
$2M
your badges
52W Range
$3–$27
Analyst Rating
BUY
Price Target
·
P/E
-3.7
ROE
-117.6%
Net Profit Margin
-484.6%
Your badge strip is empty — pin a metric anywhere on this page.
CLGN Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$3.46
Market Cap
$44M
P/E
-3.7
EPS
$-0.94
Revenue
$2M
ROE
-117.6%
52W Range
$3–$27
CLGN Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
Stock splits
| Ex-date | Split | Type |
|---|---|---|
| Sept. 4, 2026 | 1-for-10 | Reverse |
10-Year Performance Revenue, net income, margins and EPS trends
Revenue$2M2017-12-31 → 2025-12-31
EPS$-0.942019-12-31 → 2025-12-31
Free Cash Flow$-9M2019-12-31 → 2025-12-31
Net margin-484.6%2019-12-31 → 2025-12-31
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | CLGN | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/E | -3.75Y avg ≈159.7 | ≈159.7 | · | · | |
| P/S | 18.75Y avg ≈81.3 | ≈81.3 | · | · | |
| P/B | 7.35Y avg ≈3.1 | ≈3.1 | 8.4 | Undervalued | |
| Price / FCF | -4.75Y avg ≈26.8 | ≈26.8 | · | · | |
| Price / Cash Flow | -4.75Y avg ≈6.5 | ≈6.5 | · | · | |
| Price / Tangible Book | 7.45Y avg ≈3.1 | ≈3.1 | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | CLGN | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Gross Margin | 64.8%5Y avg ≈-3.1% | ≈-3.1% | 29.3% | Top tier | |
| Operating Margin | -484.3%5Y avg ≈-1924.0% | ≈-1924.0% | -424.3% | Weak | |
| EBITDA Margin | -445.8%5Y avg ≈-1874.0% | ≈-1874.0% | -405.0% | Weak | |
| Net Profit Margin | -484.6%5Y avg ≈-1886.5% | ≈-1886.5% | -352.4% | Weak | |
| ROA | -77.9%5Y avg ≈-39.5% | ≈-39.5% | -63.1% | Weak | |
| ROE | -117.6%5Y avg ≈-52.6% | ≈-52.6% | -69.5% | Weak |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | CLGN | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Current Ratio | 2.55Y avg ≈8.1 | ≈8.1 | 3.2 | Below avg | |
| Quick Ratio | 2.15Y avg ≈5.7 | ≈5.7 | 1.6 | Strong liquidity |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
| Metric | 5Y trend | CLGN | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Asset Turnover | 0.25Y avg ≈0.2 | ≈0.2 | 0.1 | In line | |
| Inventory Turnover | 1.65Y avg ≈1.7 | ≈1.7 | · | · | |
| Receivables Turnover | 31.45Y avg ≈17.2 | ≈17.2 | · | · | |
| Revenue / Employee | ≈$60.8K | · | · | · |
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
-128.2%
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| Dec. 31, 2025 | $-2.60 | $-1.94 | -34.2% | |
| Sept. 30, 2025 | $-0.27 | $0.16 | -270.8% | |
| June 30, 2025 | $-0.28 | $-0.14 | -96.1% | |
| March 31, 2025 | $-0.13 | $-0.04 | -218.6% | |
| Dec. 31, 2024 | $-0.34 | $-0.28 | -21.2% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2M | $515.0K | $11M | $299.0K | $16M | $6M | $2M | $5M | |
| Cost of Revenue | $835.0K | $2M | $2M | $400.0K | $2M | $3M | $2M | $2M | |
| Gross Profit | $2M | $-1M | $9M | $-101.0K | $14M | $3M | $439.0K | $3M | |
| R&D Expense | $8M | $11M | $10M | $10M | $8M | $4M | $4M | $4M | |
| SG&A Expense | $5M | $6M | $6M | $7M | $6M | $5M | $4M | $4M | |
| Operating Expenses | · | · | · | · | · | $34.0K | $3M | $2M | |
| Operating Income | $-11M | $-17M | $-8M | $-17M | $65.0K | $-6M | $-8M | $-4M | |
| Interest Expense | · | · | · | · | · | · | $3M | $2M | |
| Interest Income | $380.0K | $738.0K | $788.0K | $321.0K | $219.0K | · | · | · | |
| Other Non-op | $-6.0K | $642.0K | $493.0K | $172.0K | $172.0K | $-175.0K | $-4M | · | |
| Income Tax | · | $46M | $60M | · | · | · | · | · | |
| Net Income | $-11M | $-17M | $-7M | $-17M | $237.0K | $-6M | $-11M | $-6M | |
| EPS (Basic) | $-0.94 | $-1.45 | $-0.62 | $-1.53 | $0.02 | $-0.84 | $-2.23 | · | |
| EPS (Diluted) | $-0.94 | $-1.45 | $-0.62 | $-1.53 | $0.02 | $-0.84 | $-2.23 | · | |
| Shares (Basic) | 12,203,269 | 11,454,180 | 11,389,168 | 11,033,310 | 9,968,972 | 6,886,955 | 4,986,381 | 4,384,585 | |
| Shares (Diluted) | 12,203,269 | 11,454,180 | 11,389,168 | 11,033,310 | 11,966,788 | 6,886,955 | 4,986,381 | · | |
| EBITDA | $-11M | $-16M | $-6M | $-17M | $65.0K | $-6M | $-8M | · |
Balance Sheet
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $6M | $12M | $27M | $30M | $13M | $3M | $4M | $5M | |
| Receivables | $1.0K | $150.0K | · | $9.0K | $270.0K | $830.0K | $79.0K | · | |
| Inventory | $573.0K | $440.0K | $714.0K | $1M | $1M | $1M | $888.0K | $814.0K | |
| Prepaid Expense | $223.0K | $433.0K | $393.0K | $543.0K | $424.0K | $239.0K | $270.0K | · | |
| Current Assets | $7M | $13M | $28M | $32M | $45M | $6M | $5M | $7M | |
| PP&E (Net) | $1M | $2M | $3M | $3M | $3M | $2M | $2M | $1M | |
| PP&E (Gross) | $9M | $9M | $9M | $8M | $7M | $6M | $5M | · | |
| Accum. Depreciation | $8M | $7M | $6M | $5M | $4M | $3M | $3M | · | |
| Intangibles | $73.0K | $131.0K | $188.0K | $245.0K | $243.0K | $82.0K | · | · | |
| Total Assets | $11M | $19M | $34M | $38M | $51M | $11M | $11M | $9M | |
| Short-term Debt | · | · | · | $321.0K | $219.0K | · | · | · | |
| Current Liabilities | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $2M | |
| Capital Leases | $2M | $2M | $3M | $2M | $3M | $3M | $3M | · | |
| Total Liabilities | $5M | $5M | $6M | $5M | $6M | $6M | $7M | $3M | |
| Long-term Debt | · | · | · | · | $30.0K | $11.0K | $63.0K | · | |
| Total Debt | · | · | · | $321.0K | $219.0K | · | · | · | |
| Common Stock | $5M | $5M | $5M | $5M | $5M | $3M | $2M | · | |
| Retained Earnings | $-125M | $-113M | $-97M | $-90M | $-73M | $-73M | $-67M | $-56M | |
| AOCI | $-969.0K | $-969.0K | $-969.0K | $-969.0K | · | · | · | · | |
| Stockholders' Equity | $6M | $13M | $28M | $32M | $45M | $4M | $4M | $5M | |
| Liabilities + Equity | $11M | $19M | $34M | $38M | $51M | $11M | $11M | · | |
| Shares Outstanding | 12,803,006 | 11,454,512 | 11,452,672 | 11,186,481 | 10,722,024 | 6,963,838 | 5,670,829 | · |
Cash Flow
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| D&A | $912.0K | $1M | $1M | $1M | $773.0K | $660.0K | $539.0K | $342.0K | |
| Stock-based Comp | $999.0K | $2M | $2M | $2M | $2M | · | · | · | |
| Other Non-cash | $159.0K | $-241.0K | $1M | · | · | · | · | · | |
| Operating Cash Flow | $-9M | $-14M | $-3M | $-14M | $3M | $-4M | $-6M | $-1M | |
| CapEx | $28.0K | $483.0K | $954.0K | $1M | $1M | $437.0K | $1M | $832.0K | |
| Investing Cash Flow | $-27.0K | $-539.0K | $-1M | $29M | $-32M | $-519.0K | $-1M | $-832.0K | |
| Stock Issued | · | · | · | · | $50.0K | · | · | · | |
| Net Stock Activity | · | · | · | · | $50.0K | · | · | · | |
| Financing Cash Flow | $3M | $9.0K | $1M | $2M | $39M | $4M | $5M | $3M | |
| Net Change in Cash | $-6M | $-15M | $-3M | $16M | $10M | $-445.0K | · | · | |
| Taxes Paid | $16.0K | $62.0K | $8.0K | $31.0K | · | · | · | $176.0K | |
| Free Cash Flow | $-9M | $-15M | $-4M | $-15M | $1M | $-5M | $-7M | · |
Profitability
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 64.8% | -215.5% | 81.8% | -33.8% | 87.2% | 51.1% | 18.9% | · | |
| Operating Margin | -484.3% | -3349.7% | -68.5% | -5718.1% | 0.42% | -91.2% | -329.2% | · | |
| Net Margin | -484.6% | -3225.1% | -64.0% | -5660.5% | 1.5% | -94.1% | -481.6% | · | |
| EBITDA Margin | -445.8% | -3148.2% | -58.5% | -5718.1% | 0.42% | -91.2% | -329.2% | · | |
| ROA | -77.9% | -62.9% | -19.5% | -38.0% | 0.76% | -53.5% | -114.5% | · | |
| ROE | -117.6% | -79.5% | -23.2% | -43.7% | 0.96% | -134.8% | -234.8% | · |
Liquidity & Solvency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.5 | 4.4 | 8.6 | 10.2 | 15.0 | 1.7 | 1.5 | · | |
| Quick Ratio | 2.1 | 4.1 | 8.2 | 9.6 | 4.5 | 1.2 | 1.1 | · | |
| Debt / Equity | · | · | · | 0.0 | 0.0 | · | · | · | |
| Interest Coverage | · | · | · | · | · | · | -2.3 | · |
Efficiency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.0 | 0.3 | 0.0 | 0.5 | 0.6 | 0.2 | · | |
| Inventory Turnover | 1.6 | 2.8 | 1.9 | 0.3 | 1.7 | 2.8 | 2.2 | · | |
| Receivables Turnover | 31.4 | 6.9 | · | 2.1 | 28.4 | 13.5 | · | · |
Per Share
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.47 | $1.18 | $2.47 | $3.00 | $4.19 | $0.64 | · | · | |
| Revenue / Share | $0.19 | $0.04 | $0.96 | $0.03 | $1.31 | · | · | · | |
| Cash Flow / Share | $-0.77 | $-1.23 | $-0.24 | $-1.24 | $0.21 | · | · | · | |
| Cash / Share | $0.44 | $1.04 | $2.33 | $2.75 | $1.22 | $0.48 | · | · | |
| EPS (TTM) | $-0.94 | $-1.45 | $-0.62 | $-1.53 | $0.02 | $-0.84 | $-2.23 | · |
Valuation (TTM)
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $2M | $515.0K | $11M | $299.0K | $16M | $6M | $2M | · | |
| Net Income TTM | $-11M | $-17M | $-7M | $-17M | $237.0K | $-6M | $-11M | · | |
| Market Cap | $18M | $41M | $73M | $90M | $176M | $75M | · | · | |
| Enterprise Value | · | · | · | $61M | $163M | · | · | · | |
| P/E | -1.5 | -2.5 | -10.3 | -5.5 | 818.0 | -12.8 | -2.6 | · | |
| P/S | 7.6 | 80.1 | 6.7 | 300.8 | 11.3 | 12.2 | · | · | |
| P/B | 2.9 | 3.1 | 2.6 | 2.8 | 3.9 | 16.8 | · | · | |
| P / Tangible Book | 3.0 | 3.1 | 2.6 | 2.8 | 3.9 | 17.1 | · | · | |
| P / Cash Flow | -1.9 | -2.9 | -26.5 | -6.6 | 70.5 | -16.9 | · | · | |
| P / FCF | -1.9 | -2.8 | -19.7 | -6.0 | 164.2 | -15.3 | · | · | |
| EV / EBITDA | · | · | · | -3.5 | 2512.3 | · | · | · | |
| EV / FCF | · | · | · | -4.0 | 152.2 | · | · | · | |
| EV / Revenue | · | · | · | 202.7 | 10.4 | · | · | · | |
| Earnings Yield | -67.1% | -40.3% | -9.7% | -18.3% | 0.12% | -7.8% | -39.1% | · |
Valuation (TTM)
| Metric | Trend | Q4 2018 | Q4 2017 |
|---|---|---|---|
| Revenue TTM | $5M | $463.0K | |
| Net Income TTM | $-6M | $-6M |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Revenue | $2M | $515.0K | $11M | $299.0K | $16M |
| Gross Margin % | 64.8% | -215.5% | 81.8% | -33.8% | 87.2% |
| Operating Margin % | -484.3% | -3349.7% | -68.5% | -5718.1% | 0.42% |
| Net Income | $-11M | $-17M | $-7M | $-17M | $237.0K |
| Diluted EPS | $-0.94 | $-1.45 | $-0.62 | $-1.53 | $0.02 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Debt / Equity | · | · | · | 0.0 | 0.0 |
| Current Ratio | 2.5 | 4.4 | 8.6 | 10.2 | 15.0 |
| Quick Ratio | 2.1 | 4.1 | 8.2 | 9.6 | 4.5 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Free Cash Flow | $-9M | $-15M | $-4M | $-15M | $1M |
Institutional owners (13F) 16 filers · $1.1M total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders
16
Value held
$1.1M
New positions
1
Exited positions
6
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 1 (-4 vs prior Q) | 6 (+5 vs prior Q) | 4 (-2 vs prior Q) | 4 (0 vs prior Q) | +142K |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| AMH Equity Ltd | $538,000 | 200,000 | 48.06% | Shares |
| PINNACLE ASSOCIATES LTD | $255,277 | 731,663 | 22.81% | Shares |
| VILLERE ST DENIS J & CO LLC | $211,572 | 606,400 | 18.90% | Shares |
| BROWN ADVISORY INC | $36,541 | 104,731 | 3.26% | Shares |
| RENAISSANCE TECHNOLOGIES LLC | $21,457 | 61,500 | 1.92% | Shares |
| Pathstone Holdings, LLC | $19,888 | 57,000 | 1.78% | Shares |
| CITADEL ADVISORS LLC | $18,736 | 53,700 | 1.67% | Shares |
| Legacy Wealth Managment, LLC/ID | $8,087 | 23,179 | 0.72% | Shares |
| WATERS PARKERSON & CO., LLC | $4,623 | 13,250 | 0.41% | Shares |
| XTX Topco Ltd | $4,564 | 13,081 | 0.41% | Shares |
| UBS Group AG | $361 | 1,035 | 0.03% | Shares |
| OSAIC HOLDINGS, INC. | $120 | 345 | 0.01% | Shares |
| SBI Securities Co., Ltd. | $70 | 200 | 0.01% | Shares |
| Strive Financial Group ,LLC | $59 | 169 | 0.01% | Shares |
| FNY Investment Advisers, LLC | $1 | 5,250 | 0.00% | Shares |
| MORGAN STANLEY | $1 | 1 | 0.00% | Shares |
Activists & 5%+ owners 3 positions
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| Elizabeth S. Loewenbaum, George Walter Loewenbaum, Loewenbaum Lilian S., The Elizabeth Scott Loewenbaum 1992 Trust, The Loewenbaum 1992 Trust, The Loewenbaum Residence Trust FBO Anna Loewenbaum, The Waterproof Partnership, Ltd. | Aug. 21, 2026 | 17.50% | Amendment | Passive investment | SEC |
| Loewenbaum Lilian S., George Walter Loewenbaum, Elizabeth S. Loewenbaum, The Loewenbaum 1992 Trust, The Waterproof Partnership, Ltd., The Loewenbaum Residence Trust FBO Anna Loewenbaum, The Elizabeth Scott Loewenbaum 1992 Trust, Patrick Chalmers, Reginald J. Hargrove, Nachum Shamir ×5 filings | July 31, 2026 | 25.00% | Amendment | Passive investment | SEC |
| Ami Sagy ×5 filings | Nov. 28, 2025 | 12.90% | Amendment | Passive investment | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Company insiders 2 insiders · 2 officers · 0 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Eran Rotem | Deputy CEO and CFO | Sept. 3, 2026 A | 516,372 | 0 | 0 | $0 |
| Bar Berta Abelis | VP Legal | Sept. 3, 2026 A | 206,441 | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
CLGN Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
rating · 7 analysts
BUY
2 28.6%
Strong Buy
4 57.1%
Buy
1 14.3%
Hold
0 0.0%
Sell
0 0.0%
Strong Sell
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| CLGN | $18M | -1.5 | · | -484.6% | -117.6% | 64.8% |
| CMMB | · | 91.7 | · | · | -69.5% | · |
| NRSN | $25M | -1.7 | · | · | -2175.0% | · |
| ENLV | $167M | 0.0 | · | · | 126.2% | · |
| EVGN | · | 1.0 | · | -220.2% | 1107.0% | -6.2% |
| SLXN | · | 0.2 | · | · | · | · |
| SCNI | $9.88B | · | · | -633.6% | -91.9% | -202.3% |
| URGN | $1.13B | · | 21.4% | -139.8% | 154.4% | 88.7% |
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 20-F filed Mar 26, 2026